VBL Therapeutics to Report Third Quarter 2020 Financial Results on November 16

TEL AVIV, Israel, Nov. 02, 2020 (GLOBE NEWSWIRE) — VBL Therapeutics (Nasdaq: VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for cancer, today announced that it will host a conference call and live audio webcast on Monday, November 16, 2020 at 8:30am Eastern Time to report third quarter ended September 30, 2020 financial results and to provide a corporate update.

About VBL
Vascular Biogenics Ltd., operating as VBL Therapeutics, is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class treatments for areas of unmet need in cancer and immune/inflammatory indications. VBL has developed three platform technologies: a gene-therapy based technology for targeting newly formed blood vessels with focus on cancer, an antibody-based technology targeting MOSPD2 for anti-inflammatory and immuno-oncology applications, and the Lecinoxoids, a family of small-molecules for immune-related indications. VBL’s lead oncology product candidate, ofranergene obadenovec (VB-111), is a first-in-class, targeted anti-cancer gene-therapy agent that is being developed to treat a wide range of solid tumors. It is conveniently administered as an IV infusion once every 6-8 weeks. It has been observed to be well-tolerated in >300 cancer patients and demonstrated activity signals in a VBL-sponsored “all comers” Phase 1 trial as well as in three VBL-sponsored tumor-specific Phase 2 studies. Ofranergene obadenovec is currently being studied in a VBL-sponsored Phase 3 potential registration trial for platinum-resistant ovarian cancer.

INVESTOR CONTACT:
Michael Rice
LifeSci Advisors, LLC
(646) 597-6979

 

Source Article

Read more

HEXO Corp to Release Fourth Quarter and Fiscal Year 2020 Financial Results and Host Investor Webcast

OTTAWA, Oct. 27, 2020 (GLOBE NEWSWIRE) — HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NYSE: HEXO) plans to release its complete financial results for the quarter and fiscal year ended July 31, 2020, after market hours on Thursday, October 29, 2020, as well as host a webcast for investors and analysts beginning at 8:30 a.m. EDT on Friday October 30, 2020.

Webcast Details
Date: October 30, 2020
Time: 8:30 a.m. EDT
Webcast:  https://event.on24.com/wcc/r/2771524/47E7001045651D265D3F12D203F6F5A4

For previous quarterly results and recent press releases, see hexocorp.com.

About HEXO

HEXO Corp is an award-winning consumer packaged goods cannabis company that creates and distributes innovative products to serve the global cannabis market. The Company serves the Canadian adult-use markets under its HEXO Cannabis, Up Cannabis and Original Stash brands, and the medical market under HEXO medical cannabis. For more information please visit hexocorp.com.

Forward Looking Statements

This press release contains forward-looking information and forward-looking statements within the meaning of applicable securities laws (“forward-looking statements”). Forward-looking statements are based on certain expectations and assumptions and are subject to known and unknown risks and uncertainties and other factors that could cause actual events, results, performance and achievements to differ materially from those anticipated in these forward-looking statements. Forward-looking statements should not be read as guarantees of future performance or results. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements as a result of new information or future events, or for any other reason.

Investor Relations:
[email protected]
www.hexocorp.com 

Media Relations:
(819) 317-0526
[email protected] 

Source Article

Read more

Trxade Group Reports Record Third Quarter 2020 Financial Results

Revenues Increase 174% to Third Quarter Record of $6.3 Million; Continues Nationwide Platform Expansion

TAMPA, FL, Oct. 26, 2020 (GLOBE NEWSWIRE) — Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, has provided its financial results for the third quarter ended September 30, 2020.

Selected Financial Highlights

$ in millions

 

Q3
2020

 

 

Q3
2019

 

 

% Increase
(Decrease)

 

Revenues

 

$

6.3

 

 

$

2.3

 

 

 

174

%

Gross Profit

 

$

1.9

 

 

$

1.3

 

 

 

47

%

Gross Margin

 

 

30.5

%

 

 

56.7

%

 

 

(26.2

)%

Net Income

 

$

0.14

 

 

$

0.03

 

 

 

402

%

Adjusted EBITDA*

 

$

0.67

 

 

$

0.27

 

 

 

150

%

*

Adjusted EBITDA is a non-GAAP financial measure and is described in relation to its most directly comparable GAAP measure under “Use of Non-GAAP Financial Information” below.

Third Quarter 2020 and Subsequent Operational Highlights

 

Trxade continued to expand its platform nationwide, adding 144 new independent pharmacies in Q3 2020, bringing the total registered pharmacy members to around 11,800.

 

 

 

 

Launched Bonum+, a B2B platform under the Company’s telehealth subsidiary Bonum Health, which bundles telehealth, a COVID-19 risk assessment tool and a Personal Protective Equipment (PPE) purchasing tool through a secure mobile dashboard for corporate clients.

 

 

 

 

Announced prescription savings partnership with SingleCare, a free prescription savings service, to supplement Bonum Health’s enterprise telehealth solutions with prescription discounts offered to national, regional and local pharmacies to promote the benefit to uninsured patients and underserved communities.

Management Commentary

“The third quarter was highlighted by our impressive financial results, growing revenues 174% year-over-year, due to both robust PPE sales and ever more pharmacies joining the Trxade marketplace platform,” said Suren Ajjarapu, Chairman and Chief Executive Officer. “The COVID-19 pandemic has only underscored the importance of an integrated platform like ours, which enables independent pharmacies to remain competitive and profitable in a changing drug procurement marketplace.”

“The Trxade marketplace platform at the core of our business has continued to grow, with 144 new pharmacies added in the quarter – bringing our total to around 11,800,” added Mr. Ajjarapu.

“Our telehealth subsidiary, Bonum Health, continues to expand the breadth of its service offerings, providing not only telehealth solutions, allowing individuals to speak with a doctor and obtain prescriptions remotely – but further allowing them to purchase prescriptions at a discount through partnerships with companies like SingleCare, and identify a pharmacy near them for pickup. We have concurrently expanded our offerings to employers, who can use our Bonum+ platform to manage COVID-19 risk through a comprehensive interface, helping enable employees to safely return to work.”

“We are a nimble organization and remain well-positioned to address emerging opportunities in the industry through our various business units, having created an unrivaled drug procurement marketplace platform for independent pharmacies, as well as a comprehensive healthcare solution for consumers centered around the independent pharmacy ecosystem. I look forward to our continued progress in the months ahead – creating sustainable, long-term value for our stockholders,” concluded Mr. Ajjarapu.

Third Quarter 2020 Financial Summary

 

Revenues for the third

Read more

Pittman Expands Financial Aid For Coronavirus Patients, Families

MILLERSVILLE, MD — Anne Arundel County Executive Steuart Pittman launched three initiatives Thursday to help locals weather the coronavirus fallout. The programs will help residents pay bills, find resources and cope with virus-related deaths.

Water Shutoffs

The first initiative looks to help struggling families pay their water bills. Pittman announced the relief effort at a press conference in front of a Millersville water tower.

About 20,000 county residents are behind on their water payements, Pittman said. That’s up 19,000 from this time last year, the county executive added.

“If we don’t help these people, they could not only have their water cut off, but the liens that we are required to put on their homes, and the subsequent foreclosure proceedings could leave them homeless,” Pittman said in a press release after the conference. “Helping to pay their bills is essential.”

Pittman recently bought time for these families by signing Executive Order 30. The mandate prohibited water shutoffs for nonpayment until Nov. 16.

The county will mail applications for the Water Bill Relief Program to residents who qualify. Interested applicants may also dial (410) 222-1144 or email [email protected] TTY users should call Maryland Relay at 7-1-1.

Family Resources

Pittman also announced the COVID Care Coordination Program, an extension of the Department of Health’s contract tracing. The program’s case managers will reach out to people who test positive for coronavirus. The bilingual workers can help find food, shelter, housing, commodities and financial assistance.

The final initiative addresses the pandemic’s effects on mental health. This COVID Recovery and Grief Support Program will offer counseling to families who lost a loved one to coronavirus.

The extra money will bolster the mental health warm line, which has answered more calls during the pandemic. Residents can reach the line at (410) 768-5522.

“What we are experiencing is an increase in the number of individuals who are seeking additional mental health support, many of whom have financial barriers,” said Adrienne Mickler, the executive director of the Anne Arundel County Mental Health Agency. “These funds will support urgent care appointments and follow up treatment.”

CARES Act Check-In

Pittman will fund his $2 million plan with money from the Coronavirus, Aid, Relief, and Economic Security Act, better known as the CARES Act. Anne Arundel County got $101.1 million in CARES Act funding after Congress passed the stimulus package in March.

The county executive’s announcement came hours before Gov. Larry Hogan announced his $250 million plan to keep Maryland’s small businesses afloat. Hogan stressed the importance of spending CARES Act money soon, noting that it expires at the end of the year.

Pittman said that Anne Arundel County has about $25 million to $30 million left in its CARES Act account. Residents can track the county’s coronavirus spending and find resources at this link. The website shows that Anne Arundel has about $52.2 million of CARES Act money remaining, but Pittman noted that the portal needs to be updated with the county’s latest expenditures.

“Water bill

Read more

HSG Foresees Major Potential Financial Impact on Employed Physician Networks and Medical Groups from 2021 Proposed Medicare Physician Fee Schedule

Healthcare Consultants Urge Hospitals and Health Systems to Start Planning for Impact on Physician Compensation and Medicare Payments for Professional Services.

Neal D. Barker, Partner at HSG, a national healthcare consulting firm is the author of "Changes to the 2021 Medicare Physician Fee Schedule Could Have Major Impact on Physician Compensation." The article is available for download at the website, hsgadvisors.com.
Neal D. Barker, Partner at HSG, a national healthcare consulting firm is the author of “Changes to the 2021 Medicare Physician Fee Schedule Could Have Major Impact on Physician Compensation.” The article is available for download at the website, hsgadvisors.com.
Neal D. Barker, Partner at HSG, a national healthcare consulting firm is the author of “Changes to the 2021 Medicare Physician Fee Schedule Could Have Major Impact on Physician Compensation.” The article is available for download at the website, hsgadvisors.com.

Louisville, KY, Oct. 21, 2020 (GLOBE NEWSWIRE) — HSG, a national healthcare consulting firm, has published a detailed evaluation of the Centers for Medicare & Medicaid Services (CMS) 2021 Medicare Physician Fee Schedule (MPFS) Proposed Rule, which is scheduled to take effect on January 1, 2021, if approved in the Final Rule. The advisors at HSG believe the proposed changes may have a significant potential impact on physician compensation and urge healthcare executives to start planning for these proposed changes. The agency’s Fee Schedule changes cover everything from Work Relative Value Unit (wRVU) values for specific Current Procedural Terminology (CPT) codes to changes in the scope of practice policies for Advanced Practice Providers (APPs) and changes related to CMS’s quality payment program.

With more than a 10% decrease in the MPFS conversion factor, services that do not have any change in Relative Value Unit values will see a decrease in Medicare payment at the projected rate of more than 10%. The decreased reimbursement will not be fully offset by any reimbursement increases realized through the Quality Payment Program paths. Changes related to outpatient and office evaluation and management (E&M) service code determinations and requirements, along with permanent and temporary additions to telehealth codes, will add to compensation complications. The redefined E&M code selection criteria will now be driven by medical decision making (MDM) or time spent alone – with no direct contribution by history and/or exam elements.

“Assuming these changes are included when the Final Rule is published in early December, many industry organizations, consultancies, and provider advocacy groups are projecting significant increases in provider productivity-based compensation if the providers’ E&M profile remains unchanged,” explained Neal Barker, Partner at HSG. “Ultimately, hospitals and health systems may face a situation in which payments from Medicare will decrease while their physician compensation requirements will significantly increase based on the widespread use of wRVU-based compensation models for employed physicians and APPs.”

As the roll-out date for the new Fee Schedule grows closer, HSG is working with healthcare systems to help them gain an understanding of the potential impact on the network.  Then HSG works with the organization to build a model to address changes to wRVU targets and bonus conversion factors that yield productive compensation levels that are financially sustainable and uphold fair market value and commercial reasonableness. Coincident with the compensation impact review, HSG conducts a series of provider

Read more